These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1420095)
1. LDL binding sites on platelets differ from the "classical" receptor of nucleated cells. Pedreño J; de Castellarnau C; Cullaré C; Sánchez J; Gómez-Gerique J; Ordóñez-Llanos J; González-Sastre F Arterioscler Thromb; 1992 Nov; 12(11):1353-62. PubMed ID: 1420095 [TBL] [Abstract][Full Text] [Related]
2. Platelet LDL receptor recognizes with the same apparent affinity both oxidized and native LDL. Evidence that the receptor-ligand complexes are not internalized. Pedreño J; de Castellarnau C; Cullaré C; Ortín R; Sánchez JL; Llopart R; González-Sastre F Arterioscler Thromb; 1994 Mar; 14(3):401-8. PubMed ID: 8123645 [TBL] [Abstract][Full Text] [Related]
3. Platelet integrin alpha IIb beta 3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets. Pedreño J; Fernández R; Cullaré C; Barceló A; Elorza MA; de Castellarnau C Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):156-63. PubMed ID: 9012651 [TBL] [Abstract][Full Text] [Related]
4. Proteolytic susceptibility of platelet low density lipoprotein receptor. Pedreño J; Fernández R Lipids; 1995 Oct; 30(10):927-33. PubMed ID: 8538380 [TBL] [Abstract][Full Text] [Related]
5. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia. Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008 [TBL] [Abstract][Full Text] [Related]
6. Interaction of plasma lipoproteins with human platelets. Curtiss LK; Plow EF Blood; 1984 Aug; 64(2):365-74. PubMed ID: 6331546 [TBL] [Abstract][Full Text] [Related]
7. Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects. Shmulewitz A; Brook JG; Aviram M Biochem J; 1984 Nov; 224(1):13-20. PubMed ID: 6508753 [TBL] [Abstract][Full Text] [Related]
8. Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia. Bihain BE; Yen FT Biochemistry; 1992 May; 31(19):4628-36. PubMed ID: 1581314 [TBL] [Abstract][Full Text] [Related]
9. Molecular requirements in the recognition of low-density lipoproteins (LDL) by specific platelet membrane receptors. Pedreño J; Sánchez-Quesada JL; Cabré A; Masana L Thromb Res; 2000 Jul; 99(1):51-60. PubMed ID: 10904103 [TBL] [Abstract][Full Text] [Related]
10. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species. Narumiya S; Okuma M; Ushikubi F Br J Pharmacol; 1986 Jun; 88(2):323-31. PubMed ID: 3730697 [TBL] [Abstract][Full Text] [Related]
11. Interaction of a recombinant form of apolipoprotein[a] with human fibroblasts and with the human hepatoma cell line HepG2. Tam SP; Zhang X; Koschinsky ML J Lipid Res; 1996 Mar; 37(3):518-33. PubMed ID: 8728315 [TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein (LDL) binds to a G-protein coupled receptor in human platelets. Evidence that the proaggregatory effect induced by LDL is modulated by down-regulation of binding sites and desensitization of its mediated signaling. Pedreño J; Hurt-Camejo E; Wiklund O; Badimón L; Masana L Atherosclerosis; 2001 Mar; 155(1):99-112. PubMed ID: 11223431 [TBL] [Abstract][Full Text] [Related]
13. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein. Keidar S; Brook GJ; Rosenblat M; Fuhrman B; Dankner G; Aviram M Arterioscler Thromb; 1992 Apr; 12(4):484-93. PubMed ID: 1373074 [TBL] [Abstract][Full Text] [Related]
14. Defective processing and binding of low-density lipoprotein receptors in fibroblasts from a familial hypercholesterolaemic subject. Knight BL; Gavigan SJ; Soutar AK; Patel DD Eur J Biochem; 1989 Feb; 179(3):693-8. PubMed ID: 2920733 [TBL] [Abstract][Full Text] [Related]
15. Platelet interaction with high and low density lipoproteins. Aviram M; Brook JG Atherosclerosis; 1983 Mar; 46(3):259-68. PubMed ID: 6847742 [TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-associated paf (LA-paf) was found in washed human platelets and monocyte/macrophage-like U937 cells. Korth R; Zimmermann K; Richter WO Chem Phys Lipids; 1994 Apr; 70(2):109-19. PubMed ID: 8033283 [TBL] [Abstract][Full Text] [Related]
17. Platelet-modified low-density lipoproteins: studies in normal subjects and in patients with homozygous familial hypercholesterolemia. Aviram M Clin Biochem; 1987 Apr; 20(2):91-5. PubMed ID: 3608145 [TBL] [Abstract][Full Text] [Related]
18. Specific binding sites on human blood platelets for plasma lipoproteins. Koller E; Koller F; Doleschel W Hoppe Seylers Z Physiol Chem; 1982 Apr; 363(4):395-405. PubMed ID: 6281153 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. Beisiegel U; Schneider WJ; Goldstein JL; Anderson RG; Brown MS J Biol Chem; 1981 Nov; 256(22):11923-31. PubMed ID: 6271765 [TBL] [Abstract][Full Text] [Related]
20. Low density lipoprotein receptor activity in homozygous familial hypercholesterolemia fibroblasts. Semenkovich CF; Ostlund RE; Levy RA; Osa SR J Biol Chem; 1982 Nov; 257(21):12857-65. PubMed ID: 6290485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]